Atlas Trials

Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers

Clinical trial NCT00938678 · COMPLETED

Trial details

NCT number
NCT00938678
Sponsor
Hospira, now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-06-01
Primary completion
2009-10-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.